Name | Zakrytoe aktsionernoe obschestvo"NEVOMED" |
|---|
INN | 7826012718 |
|---|
KPP | 783901001 |
|---|
OGRN | 1027810265317 |
|---|
OKPO | 44294876 |
|---|
FFSM | 18430-J |
|---|
Address | 190005, G.sankt-peterburg, pr-kt Izmaylovskiy, d. D. 14, of. OFIS 322 |
|---|
Phone | +7 (812) 712-65-34 Contact details |
|---|
Fax | 712-65-08 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46.2 | Core activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 33.13 | Additional activity | Repair of electronic and optical equipment |
Registration date | 15.11.2002 |
|---|
Registering department | Registratsionnaya palata Administratsii Sankt-Peterburga |
|---|
|
ZAO"NEVOMED" (Saint Petersburg; INN 7826012718) was registered on 15 Nov 2002. The company's authorized capital as of July 1, 2012 was 25000 rub. Type of ownership of ZAO"NEVOMED" - Closed joint-stock companies. Form of ownership of ZAO"NEVOMED" - Private property. Principal activities of ZAO"NEVOMED": wholesale of medical and orthopedic goods, dental and laboratory supplies (46.46.2), repair of electronic and optical equipment (33.13). |
Economic indicators2023
Net profit (RAS) of ZAONEVOMED grew over 2023 2.50 times to 7.50 million RUB from 3.00 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 8.94% to 71.37 million RUB from 78.37 million RUB in 2022; cost of goods sold decreased by 16.08% to 44.91 million RUB from 53.52 million RUB; sales profit went up by 48.29% to 9.56 million RUB from 6.45 million RUB. 2022
Net profit (RAS) of ZAONEVOMED dropped in 2022 2.19 times to 3.00 million RUB from 6.56 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 16.41% to 78.37 million RUB from 93.76 million RUB in 2021; cost of goods sold decreased by 17.77% to 53.52 million RUB from 65.08 million RUB; sales profit fell by 36.61% to 6.45 million RUB from 10.17 million RUB. 2021
Net profit (RAS) of ZAONEVOMED dropped in 2021 2.62 times to 6.56 million RUB from 17.18 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 34.75% to 93.76 million RUB from 143.69 million RUB in 2020; cost of goods sold decreased by 37.40% to 65.08 million RUB from 103.97 million RUB; sales profit fell 2.31 times to 10.17 million RUB from 23.50 million RUB. 2020
Net profit (RAS) of ZAONEVOMED grew over 2020 1.71 times to 17.18 million RUB from 10.04 million RUB over 2019, the company informed. Revenue increased in the accounting period by 18.81% to 143.69 million RUB from 120.94 million RUB over 2019; cost of goods sold grew by 21.04% to 103.97 million RUB from 85.90 million RUB; sales profit went up by 43.05% to 23.50 million RUB from 16.43 million RUB. 2019
Net profit (RAS) of ZAONEVOMED grew over 2019 by 30.56% to 10.04 million RUB from 7.69 million RUB over 2018, the company informed. Revenue increased in the accounting period 1.62 times to 120.94 million RUB from 74.44 million RUB over 2018; cost of goods sold grew 1.72 times to 85.90 million RUB from 50.01 million RUB; sales profit went up 1.76 times to 16.43 million RUB from 9.34 million RUB. 2018
Net profit (RAS) of ZAONEVOMED dropped in 2018 by 44.22% to 7.69 million RUB from 13.78 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 35.15% to 74.44 million RUB from 114.79 million RUB in 2017; cost of goods sold decreased by 34.98% to 50.01 million RUB from 76.93 million RUB; sales profit fell by 48.81% to 9.34 million RUB from 18.25 million RUB. 2014
Net profit (RAS) of ZAONevomed grew over 2014 by 17.45% to 18.42 million RUB from 15.68 million RUB over 2013, the company informed. Revenue increased in the accounting period by 15.19% to 165.32 million RUB from 143.52 million RUB over 2013; cost of goods sold grew by 14.00% to 103.21 million RUB from 90.53 million RUB; sales profit went up by 16.76% to 23.60 million RUB from 20.21 million RUB. 2012
Net profit (RAS) of ZAONevomed dropped in 2012 by 37.44% to 31.15 million RUB from 49.80 million RUB over the same period in 2011, the company informed. Revenue decreased in the accounting period by 15.92% to 218.16 million RUB from 259.47 million RUB in 2011; cost of goods sold decreased by 9.16% to 177.08 million RUB from 194.94 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|